HIM
TMDI

HawsGoodwin Investment Management’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

HawsGoodwin Investment Management’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,700
Closed -$22K – 116
2020
Q4 		$22K Hold
12,700
– – 0.01% 94
2020
Q3 		$9K Hold
12,700
– – ﹤0.01% 86
2020
Q2 		$11K Hold
12,700
– – ﹤0.01% 83
2020
Q1 		$3K Hold
12,700
– – ﹤0.01% 91
2019
Q4 		$6K Buy
+12,700
New +$7.8K ﹤0.01% 94

Other funds holding TMDI

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CCG
Ceeto Capital Group Coral Gables, Florida $326M AUM 24.81% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
COF
Capital One Financial Mclean, Virginia $141M AUM 2.36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AI
Accredited Investors Edina, Minnesota $2.31B AUM 33.7% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

HawsGoodwin Investment Management's TMDI Position: Q1 2021 in Review

HawsGoodwin Investment Management sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2021, closing a stake of 12,700 shares — an estimated $22K sold.

HawsGoodwin Investment Management first reported a position in TMDI in Q4 2019 and held it in 5 quarters. The position peaked at $22K in Q4 2020. 55 funds tracked by Wall St. Rank hold TMDI as of Q1 2021.

  • HawsGoodwin Investment Management reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • HawsGoodwin Investment Management sold 12,700 Titan Medical Inc. Ordinary Shares shares in Q1 2021, an estimated $22K.
  • HawsGoodwin Investment Management first reported a position in Titan Medical Inc. Ordinary Shares in Q4 2019 and held it in 5 quarters.
  • HawsGoodwin Investment Management's Titan Medical Inc. Ordinary Shares position peaked at $22K in Q4 2020.
  • 55 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2021.

Based on HawsGoodwin Investment Management's 13F filing for Q1 2021, filed 5 May 2021.